These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
294 related items for PubMed ID: 9784659
1. Bronchial hyperresponsiveness, hypersensitivity to analgesics and urinary leukotriene E4 excretion in patients with aspirin-intolerant asthma. Yoshida S, Nakagawa H, Yamawaki Y, Sakamoto H, Akahori K, Nakabayashi M, Sakamoto M, Hasegawa H, Shoji T, Tajimab T, Amayasu H. Int Arch Allergy Immunol; 1998 Oct; 117(2):146-51. PubMed ID: 9784659 [Abstract] [Full Text] [Related]
2. Efficacy of leukotriene receptor antagonist in bronchial hyperresponsiveness and hypersensitivity to analgesic in aspirin-intolerant asthma. Yoshida S, Sakamoto H, Ishizaki Y, Onuma K, Shoji T, Nakagawa H, Hasegawa H, Nakabayashi M, Amayasu H. Clin Exp Allergy; 2000 Jan; 30(1):64-70. PubMed ID: 10606932 [Abstract] [Full Text] [Related]
3. Cromolyn sodium prevents bronchoconstriction and urinary LTE4 excretion in aspirin-induced asthma. Yoshida S, Amayasu H, Sakamoto H, Onuma K, Shoji T, Nakagawa H, Tajima T. Ann Allergy Asthma Immunol; 1998 Feb; 80(2):171-6. PubMed ID: 9494450 [Abstract] [Full Text] [Related]
9. Urinary LTE4 is higher after nasal provocation test with L-ASA in bronchial than in only nasal responders. Micheletto C, Visconti M, Tognella S, Trevisan F, Dal Negro RW. Eur Ann Allergy Clin Immunol; 2007 May; 39(5):162-6. PubMed ID: 17626331 [Abstract] [Full Text] [Related]
10. Urinary leukotriene E4 in bronchial asthma. Smith CM, Hawksworth RJ, Thien FC, Christie PE, Lee TH. Eur Respir J; 1992 Jun; 5(6):693-9. PubMed ID: 1321055 [Abstract] [Full Text] [Related]
11. Amalgam allergy associated with exacerbation of aspirin-intolerant asthma. Yoshida S, Mikami H, Nakagawa H, Hasegawa H, Onuma K, Ishizaki Y, Shoji T, Amayasu H. Clin Exp Allergy; 1999 Oct; 29(10):1412-4. PubMed ID: 10520063 [Abstract] [Full Text] [Related]
12. Possible involvement of mast-cell activation in aspirin provocation of aspirin-induced asthma. Mita H, Endoh S, Kudoh M, Kawagishi Y, Kobayashi M, Taniguchi M, Akiyama K. Allergy; 2001 Nov; 56(11):1061-7. PubMed ID: 11703219 [Abstract] [Full Text] [Related]
16. Cysteinyl leukotrienes overproduction and mast cell activation in aspirin-provoked bronchospasm in asthma. Sladek K, Szczeklik A. Eur Respir J; 1993 Mar; 6(3):391-9. PubMed ID: 8386106 [Abstract] [Full Text] [Related]
17. Benefits from adding the 5-lipoxygenase inhibitor zileuton to conventional therapy in aspirin-intolerant asthmatics. Dahlén B, Nizankowska E, Szczeklik A, Zetterström O, Bochenek G, Kumlin M, Mastalerz L, Pinis G, Swanson LJ, Boodhoo TI, Wright S, Dubé LM, Dahlén SE. Am J Respir Crit Care Med; 1998 Apr; 157(4 Pt 1):1187-94. PubMed ID: 9563738 [Abstract] [Full Text] [Related]
18. Aspirin induced asthma (AIA) with nasal polyps has the highest basal LTE4 excretion: a study vs AIA without polyps, mild topic asthma, and normal controls. Micheletto C, Visconti M, Tognella S, Facchini FM, Dal Negro RW. Eur Ann Allergy Clin Immunol; 2006 Jan; 38(1):20-3. PubMed ID: 16544584 [Abstract] [Full Text] [Related]
19. Attenuation of aspirin-induced bronchoconstriction by sodium cromoglycate and nedocromil sodium. Robuschi M, Gambaro G, Sestini P, Pieroni MG, Refini RM, Vaghi A, Bianco S. Am J Respir Crit Care Med; 1997 Apr; 155(4):1461-4. PubMed ID: 9105094 [Abstract] [Full Text] [Related]
20. Salmeterol prevents aspirin-induced attacks of asthma and interferes with eicosanoid metabolism. Szczeklik A, Dworski R, Mastalerz L, Prokop A, Sheller JR, Nizankowska E, Cmiel A, Oates JA. Am J Respir Crit Care Med; 1998 Oct; 158(4):1168-72. PubMed ID: 9769277 [Abstract] [Full Text] [Related] Page: [Next] [New Search]